401
Views
37
CrossRef citations to date
0
Altmetric
Articles

Influence of Age and Hypertension Treatment-time on Ambulatory Blood Pressure in Hypertensive Patients

, , , , , & show all
Pages 176-191 | Received 24 Apr 2012, Accepted 25 May 2012, Published online: 19 Oct 2012

REFERENCES

  • American Diabetes Association. (2007). Diagnosis and classification of diabetes mellitus. Diabetes Care 30( Suppl 1):S42–S47.
  • Asmar R, Vol S, Brisac AM, Tichet J, Topouchian J. (2001). Reference values for clinic pulse pressure in a nonselected population. Am. J. Hypertens. 14:415–418.
  • Ayala DE, Hermida RC, Mojón A, Fernández JR. (2013a). Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications. Chronobiol. Int. 30: 340–352.
  • Ayala DE, Moyá A, Crespo JJ, Castiñeira C, Domínguez-Sardiña M, Gomara S, Sineiro E, Mojón A, Fontao MJ, Hermida RC, on behalf of the Hygia Project Investigators. (2013b). Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int. 30: 99–115.
  • Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. (2007). Predictors of all-cause mortality in clinical ambulatory monitoring. Unique aspects of blood pressure during sleep. Hypertension 49:1235–1241.
  • Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O'Brien E, Staessen JA. (2007). Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370:1219–1229.
  • Bouhanick B, Bongard V, Amar J, Bousquel S, Chamontin B. (2008). Prognostic value of nocturnal blood pressure and reverse-dipping status on the occurrence of cardiovascular events in hypertensive diabetic patients. Diabetes Metab. 34:560–567.
  • Brotman DJ, Davidson MB, Boumitri M, Vidt DG. (2008). Impaired diurnal blood pressure variation and all-cause mortality. Am. J. Hypertens. 21:92–97.
  • Burr ML, Dolan E, O'Brien EW, O'Brien ET, McCormack P. (2008). The value of ambulatory blood pressure in older adults: the Dublin outcome study. Age Ageing 37:201–206.
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Rocella EJ, and the National High Blood Pressure Education Coordinating Committee. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 289:2560–2571.
  • Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E. (2003). Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N. Engl. J. Med. 348:2407–2415.
  • Crespo C, Aboy M, Fernández JR, Mojón A. (2012). Automatic identification of activity-rest periods based on actigraphy. Med. Biol. Eng. Comput. 50:329–340.
  • Crespo C, Fernández JR, Aboy M, Mojón A. (2013). Clinical application of a novel automatic algorithm for actigraphy-based activity and rest period identification to accurately determine awake and asleep ambulatory blood pressure parameters and cardiovascular risk. Chronobiol. Int. 30: 43–54.
  • Di Iorio A, Marini E, Lupinetti M, Zito M, Abate G. (1999). Blood pressure rhythm and prevalence of vascular events in hypertensive subjects. Age Ageing 28:23–28.
  • Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. (2005). Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46:156–161.
  • Dolan E, Thijs L, Li Y, Atkins N, McCormack P, McClory S, O'Brien E, Staessen JA, Stanton AV. (2006). Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension 47:365–370.
  • Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. (2008). Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 51:55–61.
  • Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, Björklund-Bodegard K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Ibsen H, O'Brien E, Wang J, Staessen JA. (2010). Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J. Hypertens. 28:2036–2045.
  • Fernández JR, Hermida RC. (1998). Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol. Int. 15:191–204.
  • Fernández JR, Mojón A, Hermida RC. (2004). Comparison of parameters from rhythmometric models with multiple components on hybrid data. Chronobiol. Int. 21:467–482.
  • Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Frauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. (2005). Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752.
  • Hermida RC. (1999). Time-qualified reference values for 24 h ambulatory blood pressure monitoring. Blood Press. Monit. 4:137–147.
  • Hermida RC. (2007). Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study. Chronobiol. Int. 24:749–775.
  • Hermida RC, Ayala DE. (2003). Sampling requirements for ambulatory blood pressure monitoring in the diagnosis of hypertension in pregnancy. Hypertension 42:619–624.
  • Hermida RC, Fernández JR. (1996). Computation of time-specified tolerance intervals for ambulatorily monitored blood pressure. Biomed. Instrum. Technol. 30:257–266.
  • Hermida RC, Smolensky MH. (2004). Chronotherapy of hypertension. Curr. Opin. Nephrol. Hypertens. 13:501–505.
  • Hermida RC, Mojón A, Fernández JR, Ayala DE. (1996). Computer-based medical system for the computation of blood pressure excess in the diagnosis of hypertension. Biomed. Instrum. Technol. 30:267–283.
  • Hermida RC, Fernández JR, Mojón A, Ayala DE. (2000). Reproducibility of the hyperbaric index as a measure of blood pressure excess. Hypertension 35:118–125.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Calvo C. (2002a). Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis. Chronobiol. Int. 19:461–481.
  • Hermida RC, Calvo C, Ayala DE, Fernández JR, Ruilope LM, López JE. (2002b). Evaluation of the extent and duration of the “ABPM effect” in hypertensive patients. J. Am. Coll. Cardiol. 40:710–717.
  • Hermida RC, Calvo C, Ayala DE, Mojón A, López JE. (2002c). Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 20:1097–1104.
  • Hermida RC, Mojón A, Fernández JR, Alonso I, Ayala DE. (2002d). The tolerance-hyperbaric test: a chronobiologic approach for improved diagnosis of hypertension. Chronobiol. Int. 19:1183–1211.
  • Hermida RC, Ayala DE, Calvo C. (2005). Administration time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr. Opin. Nephrol. Hypertens. 14:453–459.
  • Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. (2007a). Chronotherapy of hypertension: administration-time dependent effects of treatment on the circadian pattern of blood pressure. Adv. Drug Deliv. Rev. 59:923–939.
  • Hermida RC, Ayala DE. Fernandez JR, Mojón A, Calvo C. (2007b). Influence of measurement duration and frequency on ambulatory blood pressure monitoring. Rev. Esp. Cardiol. 60:131–138.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2010). Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol. Int. 27:1629–1651.
  • Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH. (2011a). Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. Am. J. Hypertens. 24:383–391.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011b). Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J. Am. Coll. Cardiol. 58:1165–1173.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011c). Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care 34:1270–1276.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011d). Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J. Am. Soc. Nephrol. 22:2313–2321.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2012). Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes. Am. J. Hypertens. 25:325–334.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A. (2013a). Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol. Int. 30: 68–86.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F. (2013b). Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol. Int. 30: 280–314.
  • Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. (2013c). Ambulatory blood pressure monitoring: importance of sampling rate and duration—48 versus 24 hours—on the accurate assessment of cardiovascular risk. Chronobiol. Int. 30: 55–67.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013d). Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level—the “normotensive non-dipper” paradox. Chronobiol Int. 30: 87–98.
  • Ingelsson E, Bjorklund-Bodegard K, Lind L, Arnlov J, Sundstrom J. (2006). Diurnal blood pressure pattern and risk of congestive heart failure. JAMA 295:2859–2866.
  • Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. (2003). Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 107:1401–1406.
  • Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. (2005). Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality. The Ohasama Study. Hypertension 45:240–245.
  • Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, for the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI). (2009). A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150:604–612.
  • Madhavan S, Ooi WL, Cohen H, Alderman MH. (1994). Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 23:395–401.
  • Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker HAJ, Zanchetti A. (2007). 2007 guidelines for the management of arterial hypertension.The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25:1105–1187.
  • Manfredini R, Gallerani M, Portaluppi F, Fersini C. (1996a). Relationships of the circadian rhythms of thrombotic, ischemic, hemorrhagic, and arrhythmic events to blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:141–158.
  • Manfredini R, Portaluppi F, Grandi E, Fersini C, Gallerani M. (1996b). Out-of-hospital sudden death referring to an emergency department. J. Clin. Epidemiol. 49:865–868.
  • Manfredini R, Portaluppi F, Salmi R, Zamboni P, La Cecilia O, Kuwornu-Afi H, Regoli F, Bigoni M, Gallerani M. (1999). Seasonal variation in the occurrence of non traumatic rupture of thoracic aorta. Am. J. Emerg. Med. 17:672–674.
  • Manfredini R, Boari B, Bressan S, Gallerani M, Salmi R, Portaluppi F, Mehta RH. (2004). Influence of circadian rhythm on mortality after myocardial infarction: data from a prospective cohort of emergency calls. Am. J. Emerg. Med. 22:555–559.
  • Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, Nishizawa M, Kigoshi T, Uchida K. (1998). Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal events in NIDDM subjects. Diabetes 47:1501–1506.
  • National Kidney Foundation. (2002). K/DOQI clinical practice guidelines on chronic kidney disease: evaluation, classification and stratification. Am. J. Kidney Dis. 39(2 Suppl 1):S1–S266.
  • Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. (2002). Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20:2183–2189.
  • O'Sullivan C, Duggan J, Atkins N, O'Brien E. (2003). Twenty-four-hour ambulatory blood pressure in community-dwelling elderly men and women, aged 60–102 years. J. Hypertens. 21:1641–1647.
  • Palmas W, Moran A, Pickering T, Eimicke JP, Teresi J, Schwartz JE, Field L, Weinstock RS, Shea S. (2006). Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension 48:301–308.
  • Palmas W, Pickering TG, Teresi J, Schwartz JE, Moran A, Weinstock RS, Shea S. (2009). Ambulatory blood pressure monitoring and all-cause mortality in elderly people with diabetes mellitus. Hypertension 53:120–127.
  • Perloff D, Sokolow M, Cowan R. (1983). The prognostic value of ambulatory blood pressures. JAMA 249:2792–2798.
  • Portaluppi F, Hermida RC. (2007). Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. Adv. Drug Deliv. Rev. 59:940–951.
  • Portaluppi F, Smolensky MH. (2010). Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol. Int. 27:1652–1667.
  • Portaluppi F, Montanari L, Ferlini M, Gilli P. (1990). Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure. Chronobiol. Int. 7:321–327.
  • Portaluppi F, Trasforini G, Margutti A, Vergnani L, Ambrosio MR, Rossi R, Bagni B, Pansini R, degli Uberti EC. (1992). Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J. Hypertens. 10:1227–1234.
  • Portaluppi F, Cortelli P, Avoni P, Vergnani L, Maltoni P, Pavani A, Sforza E, degli Uberti EC, Gambetti P, Lugaresi E. (1994). Progressive disruption of the circadian rhythm of melatonin in fatal familial insomnia. J. Clin. Endocrinol. Metab. 78:1075–1078.
  • Portaluppi F, Vergnani L, Manfredini R, Fersini C. (1996). Endocrine mechanisms of blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:113–131.
  • Portaluppi F, Boari B, Manfredini R. (2004). Oxidative stress in essential hypertension. Curr. Pharm. Des. 10:1695–1698.
  • Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol. Int. 27:1911–1929.
  • Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. (2012). Circadian rhythms and cardiovascular health. Sleep Med. Rev. 16:151–166.
  • Smolensky MH, Portaluppi F. (1999). Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. Am. Heart J. 137(4 Pt 2):S14–S24.
  • Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F. (2007). Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 8:668–680.
  • Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. (2010). Administration-time-dependent effect of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood. Press. Monit. 15:173–180.
  • Staessen JA, Thijs L, Fagard R, ÓBrien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J, for the Systolic Hypertension in Europe (Syst-Eur) trial investigators. (1999). Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 282:539–546.
  • Trasforini G, Margutti A, Portaluppi F, Menegatti M, Ambrosio MR, Bagni B, Pansini R, Degli Uberti EC. (1991). Circadian profile of plasma calcitonin gene-related peptide in healthy man. J. Clin. Endocrinol. Metab. 73:945–951.
  • Varani K, Gessi S, Caiazza A, Rastelli G, Portaluppi F, Borea PA. (1999). Platelet alpha2-adrenoceptor alterations in patients with essential hypertension. Br. J. Clin. Pharmacol. 47:167–172.
  • Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. (1994). Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 24:793–801.
  • Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C. (1998). Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 32:983–988.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.